About Nor Consult

Our Company

showcase image Established in 2005, Nor Consult, LLC, is an independent full-service CRO specializing in clinical research of medical devices and combination products and clinical studies related to the spinal cord, and orthopedics. Our collaboration with the leading surgeons and medical centers in North America, Canada, Australia, and in European countries, allows us to maximize clinical study investments. Our proficiency in advanced study design and biostatistics, combined with efficient study management, provides the best value for our clients’ investment and has made us a leader in the industry in those specialties.

Our effectiveness is maximized through the use of industry informatics solutions; such as remote electronic data capture, secure image collection and archiving, and collaborative software platforms. In addition, we were the first to introduce an adaptive statistical design approach for investigational device exemption (IDE) studies, which is the most efficient solution for assuring the optimal sample size.

We use advanced statistical approaches such as multiple imputation statistic techniques that efficiently compensate for missing values and losses to follow-up.

We have managed large academic and industry sponsored clinical studies and supported an array of clients in North America, Europe, and Australia.

Study Leadership

The core backgrounds of Nor Consult team members and over a decade long experience enables us to provide excellent quality control and risk management services.

Branko Kopjar, MD, PhD, FACE

Dr. Branko Kopjar is the study director for the Nor Consult trials, internationally recognized scholar and expert in clinical epidemiology, biostatistics, outcomes research and health economics. He actively participates in the design, management and analysis of clinical research for more than 30 years. As a consultant, he works with a global list of pharmaceutical, medical device, venture capital, and legal firms to determine the efficacy, safety, and investment value of medical technologies.

Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), the Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN).

He serves on the editorial board and as a reviewer for a number of academic journals. In 2014, Dr. Kopjar was appointed Director of the Executive Master of Public Health program at the University of Washington. He has served as a lecturer or Visiting Professor at medical schools in China, Europe, and North America. Dr. Kopjar completed his Doctor of Medicine and Master of Science degrees at the University of Zagreb, Croatia. He went on to complete a fellowship in health economics and earned a PhD in epidemiology and health economics at the University of Oslo in Norway.

Dr. Kopjar was elected a Fellow of the American College of Epidemiologists (ACE) in 2015. In the 2000's he held the title of Adviser to the Minister of Health for two European governments.

He is credited as an author/co-author on over 440 articles, technical reports, manuscripts and abstracts. Dr. Kopjar's work has been published in academic journal such as; the American Journal of Public Health, the American Journal of Cardiology, The Journal of Neurosurgery, The Spine Journal,  The Journal of Bone and Joint surgery (Am) and the Archives of Internal Medicine. As an academic at several major global learning institutions, his teaching and research interests focus on evidence-based health care, biostatistics, clinical epidemiology, and outcomes research.

 In 2005 he was a recipient of the John M. Eisenberg Article-of-the-Year Award in Health Services Research and in 2014 Dr. Kopjar was a co-author on a paper that earned the North American Spine Society/The Spine Journal Outstanding Paper Award.